These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6628514)

  • 1. Pharmacokinetics and bioavailability of three dyphylline preparations.
    Stablein JJ; Samaan SS; Bukantz SC; Lockey RF
    Eur J Clin Pharmacol; 1983; 25(2):281-3. PubMed ID: 6628514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans.
    Straughn AB; Wood GC; Raghow G; Meyer MC
    J Pharm Sci; 1985 Mar; 74(3):335-7. PubMed ID: 4009445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of dyphylline in humans.
    Simons KJ; Simons FE
    J Pharm Sci; 1979 Oct; 68(10):1327-9. PubMed ID: 512873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of theophylline and dyphylline following intravenous injection in rabbits.
    Ng PK; Locock RA
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):509-24. PubMed ID: 523786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of a sustained-release dyphylline formulation.
    Simons KJ; Simons FE; Bierman CW
    J Clin Pharmacol; 1977 Apr; 17(4):237-41. PubMed ID: 849997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline and dyphylline pharmacokinetics in the horse.
    Ayres JW; Pearson EG; Riebold TW; Chang SF
    Am J Vet Res; 1985 Dec; 46(12):2500-6. PubMed ID: 4083583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of dyphylline elimination by uremic patients.
    Lee CC; Wang LH; Majeske BL; Marbury TC
    J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of dihydroxypropyltheophylline: a basis for rational therapy.
    Simons FE; Simons KJ; Bierman CW
    J Allergy Clin Immunol; 1975 Nov; 56(5):347-55. PubMed ID: 1181352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of orally administered dyphylline.
    Gisclon LG; Ayres JW; Ewing GH
    Am J Hosp Pharm; 1979 Sep; 36(9):1179-84. PubMed ID: 495617
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyphylline elimination kinetics in lactating women: blood to milk transfer.
    Jarboe CH; Cook LN; Malesic I; Fleischaker J
    J Clin Pharmacol; 1981 Oct; 21(10):405-10. PubMed ID: 7309903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antacid on bioavailability of a sustained-release theophylline preparation.
    Darzentas LJ; Stewart RB; Curry SH; Yost RL
    Drug Intell Clin Pharm; 1983; 17(7-8):555-7. PubMed ID: 6872853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of probenecid on dyphylline elimination.
    May DC; Jarboe CH
    Clin Pharmacol Ther; 1983 Jun; 33(6):822-5. PubMed ID: 6851414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probenecid inhibition of the renal excretion of dyphylline in chicken, rat and man.
    Acara M; Carr EA; Terry EN
    J Pharm Pharmacol; 1987 Jul; 39(7):526-30. PubMed ID: 2886621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyphylline prodrugs: plasma hydrolysis and dyphylline release in rabbits.
    Huang HP; Ayres JW
    J Pharm Sci; 1988 Feb; 77(2):104-9. PubMed ID: 3361424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of intravenous dihydroxypropyl theophylline (dyphylline) in an aminophylline-sensitive patient, and its pharmacokinetic comparison with theophylline.
    Lawyer CH; Bardana EJ; Rodgers R; Gerber N
    J Allergy Clin Immunol; 1980 May; 65(5):353-7. PubMed ID: 7372953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor absorption of an un-theophylline xanthine bronchodilator.
    Hendeles L; Weinberger M
    Am J Hosp Pharm; 1980 Feb; 37(2):169. PubMed ID: 7361784
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of clearance of dyphylline by probenecid.
    May DC; Jarboe CH
    N Engl J Med; 1981 Mar; 304(13):791. PubMed ID: 7464894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.